Details of the Drug

General Information of Drug (ID: DMYMA8G)

• Drug Name: JNJ-63682931

Indication

Disease Entry	ICD 11	Status	REF
Human papillomavirus infection	1A9Y	Phase 1/2	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D8RN3B

References

• [1] ClinicalTrials.gov (NCT03610581) Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix. U.S. National Institutes of Health.